tiprankstipranks
Trending News
More News >
Restart Life Sciences Corp. (NMLSF)
:NMLSF
US Market
Advertisement

Restart Life Sciences (NMLSF) Technical Analysis

Compare
30 Followers

Technical Sentiment

Overall Consensus
Neutral
6Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
2Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
6Bearish
Restart Life Sciences Corp.’s (NMLSF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Restart Life Sciences Corp. is a Buy.
Restart Life Sciences Corp.’s (NMLSF) 20-Day exponential moving average is 0.07, while Restart Life Sciences Corp.’s (NMLSF) share price is <$0.1, making it a Sell.
Restart Life Sciences Corp.’s (NMLSF) 50-Day exponential moving average is 0.06, while Restart Life Sciences Corp.’s (NMLSF) share price is <$0.1, making it a Buy.

Restart Life Sciences (NMLSF) Pivot Points

Aug 05, 2025, 09:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.08
0.08
0.08
0.08
0.08
0.08
0.08
Fibonacci
0.08
0.08
0.08
0.08
0.08
0.08
0.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Restart Life Sciences (NMLSF) Moving Averages

Aug 05, 2025, 09:55 AM
Period
Simple
Exponential
MA5
0.08Sell
0.08Sell
MA10
0.08Sell
0.08Sell
MA20
0.07Sell
0.07Sell
MA50
0.06Buy
0.06Buy
MA100
0.06Buy
0.06Buy
MA200
Restart Life Sciences Corp.’s (NMLSF) 10-Day exponential moving average is 0.08, while Restart Life Sciences Corp.’s (NMLSF) share price is <$0.1, making it a Sell.
Restart Life Sciences Corp.’s (NMLSF) 100-Day exponential moving average is 0.06, while Restart Life Sciences Corp.’s (NMLSF) share price is <$0.1, making it a Buy.
Restart Life Sciences Corp.’s (NMLSF) stock price is <$0.1 and Restart Life Sciences Corp.’s (NMLSF) 50-day simple moving average is 0.06, creating a Buy signal.
Restart Life Sciences Corp.’s (NMLSF) stock price is <$0.1 and Restart Life Sciences Corp.’s (NMLSF) 100-day simple moving average is 0.06, creating a Buy signal.

Restart Life Sciences (NMLSF) Technical Indicators

Aug 05, 2025, 09:55 AM
Name
Value
Implied Action
RSI (14)
53.31
Neutral
STOCH (9,6)
53.70
Neutral
STOCHRSI (14)
53.70
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
43.59
Neutral
Williams %R
-83.33
Buy
CCI (14)
-2.13
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
63.25
Neutral
ROC
0.00
Buy
Restart Life Sciences Corp.’s (NMLSF) Relative Strength Index (RSI) is 53.31, creating a Neutral signal.
Restart Life Sciences Corp.’s (NMLSF) Trend Strength Indicator (ADX) is 43.59, creating a Neutral signal.
Restart Life Sciences Corp.’s (NMLSF) Commodity Channel Index (CCI) is -2.13, creating a Neutral signal.

FAQ

Is NMLSF a Buy, Hold, or Sell?
Based on NMLSF’s technical indicators, NMLSF is a Hold.
    What is NMLSF’s RSI (14)?
    NMLSF’s RSI (14) is 53.31, which suggests NMLSF is a Neutral.
      What is NMLSF’s MACD?
      NMLSF’s MACD is <0.01, which suggests NMLSF is a Buy.
        What is NMLSF’s 5-day moving average?
        NMLSF’s 5-day moving average is 0.08, which suggests NMLSF is a Sell.
          What is NMLSF’s 20-day moving average?
          NMLSF 20-day moving average is 0.07, which suggests NMLSF is a Sell.
            What is NMLSF’s 50-day moving average?
            NMLSF’s 50-day moving average is 0.06, which suggests NMLSF is a Buy.
              What is NMLSF’s 200-day moving average?
              Currently, no data Available
              What is NMLSF’s Williams % R (14)?
              NMLSF’s Williams % R (14) is -83.33, which suggests NMLSF is a Buy.
                What is NMLSF’s CCI (14)?
                NMLSF’s CCI (14) is -2.13, which suggests NMLSF is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis